Publication:
Post-authorization safety of lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma: Early safety report of Turkish pass study

dc.contributor.authorTuğlular, A. T. Fıratlı
dc.contributor.authorPehlivan, M.
dc.contributor.authorSarı, H. I.
dc.contributor.authorAyyıldız, M. O.
dc.contributor.authorSaydam, G.
dc.contributor.authorSönmez, M.
dc.contributor.authorBesisik, S. Kalayoğlu
dc.contributor.authorÖzgür, G.
dc.contributor.authorGürkan, E.
dc.contributor.authorKaynar, L.
dc.contributor.authorÖzet, G.
dc.contributor.authorDemirkan, F.
dc.contributor.authorÖngören, S.
dc.contributor.authorÖzdoğu, H.
dc.contributor.authorGündüz, E.
dc.contributor.authorTiftik, E. N.
dc.contributor.authorSalim, O.
dc.contributor.authorTurgut, M.
dc.contributor.authorHacıhanefioğlu, A.
dc.contributor.authorÜre, U. B.
dc.contributor.authorÖzdemir, E.
dc.contributor.authorAltuntas, F.
dc.contributor.authorŞimsek, D.
dc.contributor.authorUlu, N.
dc.contributor.authorBeksaç M.
dc.contributor.buuauthorAli, R.
dc.contributor.buuauthorALİ, RIDVAN
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi
dc.date.accessioned2024-08-13T05:59:21Z
dc.date.available2024-08-13T05:59:21Z
dc.date.issued2015-06-01
dc.descriptionBu çalışma, 11-14 Haziran 2015 tarihleri arasında Vienna [Avusturya]’da düzenlenen 20. Congress of European-Hematology-Association’da bildiri olarak sunulmuştur.
dc.description.sponsorship
dc.identifier.endpage734
dc.identifier.issn0390-6078
dc.identifier.issueSupplement 1
dc.identifier.startpage734
dc.identifier.urihttps://hdl.handle.net/11452/43948
dc.identifier.volume100
dc.identifier.wos000361204904399
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherFerrata Storti Foundation
dc.relation.journalHaematologica
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectHematology
dc.titlePost-authorization safety of lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma: Early safety report of Turkish pass study
dc.typeMeeting Abstract
dspace.entity.typePublication
relation.isAuthorOfPublication578cac50-ce4d-4818-8e99-2634ef340753
relation.isAuthorOfPublication.latestForDiscovery578cac50-ce4d-4818-8e99-2634ef340753

Files

Collections